Financial Times Healthcare
Roche to cut jobs after setbacks for drugs
Roche confirmed speculation about significant job cuts to tailor its spending to tougher market conditions, but said it would not give details until later this year
Silverfleet looks to auction US asset
The private equity owner of Sterigenics, a US medical device sterilisation group, has hired JPMorgan to run an auction of the company that it hopes will raise about $800m
Cancer drug trial halted as patients fall ill
Tests in Ireland abandoned after three of 12 people receiving the treatment suffer seizures and are admitted to hospital. The Irish Medicines Board has launched an investigation into the incident
Scientists closer to malaria cure
Scientists have cured malaria in mice with a single dose of a new drug, the journal Science reports
Sanofi-Aventis/Genzyme
The troubled US biotech believes it is undervalued by the French drugmaker – but it cannot afford to be too choosy
Hunger for Genzyme deal grows keener
Genzyme's removal of some of its takeover defences – including a poison pill and staggered directors' appointments – makes the US biotech group more vulnerable to a hostile bid
Genzyme rejects Sanofi takeover
Genzyme rejected a takeover offer from Sanofi-Aventis, calling the French pharmaceutical group's $69 a share bid 'opportunistic' and 'unrealistic'
Sanofi steps up Genzyme pursuit
Sanofi-Aventis steps up its pursuit of Genzyme, outlining publicly its interest in a deal as the French pharmaceuticals group inches closer to making a hostile offer for the US biotech
Southern Cross rejects TowerBrook offer
The troubled care home group declines to enter further negotiations with TowerBrook amid an indicative takeover offer by the UK-based private equity company
A pharmaceutical experiment in design
Drugs companies are using consumer industry techniques to better understand their patients' needs
Scientists create liver cells from skin
Scientists at Cambridge University have used stem cell technology to convert skin from patients with metabolic diseases into liver cells
Scientists create liver cells from skin
Scientists at Cambridge University have used stem cell technology to convert skin from patients with metabolic diseases into liver cells
Scientists create liver cells from skin
Scientists at Cambridge University have used stem cell technology to convert skin from patients with metabolic diseases into liver cells
Challenges ahead for Sanofi chief
Chris Viehbacher needs to reinvigorate the French group's research and development pipeline for the production of new innovative drugs to replace existing ones going off patent
Challenges ahead for Sanofi chief
Chris Viehbacher needs to reinvigorate the French group's research and development pipeline for the production of new innovative drugs to replace existing ones going off patent
AstraZeneca had internal debate on drug data
Documents made public during litigation on the pharmaceutical group's antipsychotic drug Seroquel highlight apparent efforts by the group to communicate favourable data selectively to boost prescriptions
AstraZeneca had internal debate on drug data
Documents made public during litigation on the pharmaceutical group's antipsychotic drug Seroquel highlight apparent efforts by the group to communicate favourable data selectively to boost prescriptions
Conflicted interests
The fact that scientists receive funding from companies does not mean they should be excluded from policy debates and the drafting of guidelines
Conflicted interests
The fact that scientists receive funding from companies does not mean they should be excluded from policy debates and the drafting of guidelines
Four Seasons close to renegotiating its debt
Four Seasons Health Care is close to sealing a second-round renegotiation on the terms of its £600m of debt as a majority of lenders agreed to back its latest restructuring plan